Primary balloon expandable polytetrafluoroethylene-covered stenting of focal infrarenal aortic occlusive disease

Bruijnen, R.; Grimme, Frederike A.B.; Horsch, Alexander D.; Oostayen, Jacques A. van; Zeebregts, Clark J.; Reijnen, Michel M.P.J.

doi:10.1016/j.jvs.2011.08.061

Cited by 11 publications

(11 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This is in keeping with a case series performed by Bruijnen et al, who stented 12 patients with isolated infra-renal aortic disease reporting no cases of restenosis. 11 Our results affirm the conclusion that covered stents are related to an improved outcome in a kissing stent configuration and related to excellent results in isolated aortic lesions. 12 The authors acknowledge that the relatively small number of patients included in the present study accounts largely for the absence of statistically significant univariate predictors of patency.…”

Section: Discussionsupporting

confidence: 86%

“…This is in keeping with a case series performed by Bruijnen et al., who stented 12 patients with isolated infra-renal aortic disease reporting no cases of restenosis. 11 Our results affirm the conclusion that covered stents are related to an improved outcome in a kissing stent configuration and related to excellent results in isolated aortic lesions. 12…”

Section: Discussionsupporting

confidence: 86%

See 1 more Smart Citation

Outcomes of covered expandable stents for the treatment of TASC D aorto-iliac occlusive lesions

et al. 2015

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 86%

Section: Discussionsupporting

confidence: 86%

Outcomes of covered expandable stents for the treatment of TASC D aorto-iliac occlusive lesions

et al. 2015

View full text Add to dashboard Cite

show abstract

“…Covered stent placement in the aorta has few data on which to base any specific recommendations regarding use. 152 Stents should be sized appropriately to the native aorta, with consideration given for the tissue displaced (especially calcific disease). This may necessitate undersizing the stent relative to the diameter of the native normal-caliber aorta to reduce the risk of rupture, which has been reported with this approach.…”

Section: A Aortoiliac Revascularization: Catheter-based Interventionsmentioning

confidence: 99%

Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and claudication

Conte

Pomposelli

Clair

et al. 2015

Journal of Vascular Surgery

704

508

View full text Add to dashboard Cite

Peripheral arterial disease (PAD) continues to grow in global prevalence and consumes an increasing amount of resources in the United States health care system. Overall rates of intervention for PAD have been rising steadily in recent years. Changing demographics, evolution of technologies, and an expanding database of outcomes studies are primary forces influencing clinical decision making in PAD. The management of PAD is multidisciplinary, involving primary care physicians and vascular specialists with varying expertise in diagnostic and treatment modalities. PAD represents a broad spectrum of disease from asymptomatic through severe limb ischemia. The Society for Vascular Surgery Lower Extremity Practice Guidelines committee reviewed the evidence supporting clinical care in the treatment of asymptomatic PAD and intermittent claudication (IC). The committee made specific practice recommendations using the GRADE (Grades of Recommendation Assessment, Development and Evaluation) system. There are limited Level I data available for many of the critical questions in the field, demonstrating the urgent need for comparative effectiveness research in PAD. Emphasis is placed on risk factor modification, medical therapies, and broader use of exercise programs to improve cardiovascular health and functional performance. Screening for PAD appears of unproven benefit at present. Revascularization for IC is an appropriate therapy for selected patients with disabling symptoms, after a careful risk-benefit analysis. Treatment should be individualized based on comorbid conditions, degree of functional impairment, and anatomic factors. Invasive treatments for IC should provide predictable functional improvements with reasonable durability. A minimum threshold of a >50% likelihood of sustained efficacy for at least 2 years is suggested as a benchmark. Anatomic patency (freedom from restenosis) is considered a prerequisite for sustained efficacy of revascularization in IC. Endovascular approaches are favored for most candidates with aortoiliac disease and for selected patients with femoropopliteal disease in whom anatomic durability is expected to meet this minimum threshold. Conversely, caution is warranted in the use of interventions for IC in anatomic settings where durability is limited (extensive calcification, small-caliber arteries, diffuse infrainguinal disease, poor runoff). Surgical bypass may be a preferred strategy in good-risk patients with these disease patterns or in those with prior endovascular failures. Common femoral artery disease should be treated surgically, and saphenous vein is the preferred conduit for infrainguinal bypass grafting. Patients who undergo invasive treatments for IC should be monitored regularly in a surveillance program to record subjective improvements, assess risk factors, optimize compliance with cardioprotective medications, and monitor hemodynamic and patency status.

show abstract

“…Whether stenting increases patency rates over balloon angioplasty alone remains unclear. Rutger et al have shown that the use of PTFE (Polytetrafluoroethylene) -covered stents for isolated atherosclerotic lesions in the infrarenal aorta is safe, feasible, and associated with an excellent outcome [17].…”

Section: Journal Of Vascular and Endovascular Surgery Issn 2573-4482mentioning

confidence: 99%

Endovascular Treatment of Focal Infrarenal Aortic Stenosis with Absence of the Celiac Trunk - Case Report

Reis¹

2018

J Vasc Endovasc Surg

View full text Add to dashboard Cite

This case report describes a case of abdominal aortic stenotic disease treated with covered balloon-expandable stent with absence of the celiac trunk artery.Technique: Patients are selected for this strategy if they have a lesion without bifurcation involvement located at the mid segment of the infrarenal aorta or stenosis with unfavorable aortic anatomy, or severely diseased and calcified distal aorta. Conclusion:Our result in this case supports the feasibility, safety, and efficacy of stenting for stenosis of the distal infrarenal aorta.

show abstract

Primary balloon expandable polytetrafluoroethylene-covered stenting of focal infrarenal aortic occlusive disease

Cited by 11 publications

References 15 publications

Outcomes of covered expandable stents for the treatment of TASC D aorto-iliac occlusive lesions

Outcomes of covered expandable stents for the treatment of TASC D aorto-iliac occlusive lesions

Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and claudication

Endovascular Treatment of Focal Infrarenal Aortic Stenosis with Absence of the Celiac Trunk - Case Report

Contact Info

Product

Resources

About